## DOV: Dover Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%); PEG 2.13 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($183.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Dover Corporation $DOV Position Raised by iSAM Funds UK Ltd**
- Source: MarketBeat | 20251209T135621 | Somewhat-Bullish | Relevance: 98%
-  iSAM Funds UK Ltd has significantly increased its stake in Dover Corporation (NYSE:DOV) by 121.2% in the second quarter, now owning 14,933 shares valued at $2.74 million. Other institutional investors like Vanguard Group Inc., State Street Corp, and Geode Capital Management LLC have also adjusted their holdings. The article further details recent analyst ratings, financial performance metrics, dividend announcements, and insider trading activities for Dover Corporation.

**2. Invesco Ltd. Increases Holdings in Dover Corporation $DOV**
- Source: MarketBeat | 20251207T111526 | Neutral | Relevance: 98%
-  Invesco Ltd. has increased its stake in Dover Corporation (NYSE:DOV) by 21.7% during the second quarter, bringing its total holdings to 1,549,453 shares valued at $283,906,000. Other hedge funds have also adjusted their positions in Dover. Insider selling by CFO Christopher B. Woenker and SVP Ivonne M. Cabrera occurred in late November and early December.

**3. Wells Fargo Remains a Buy on Centuri Holdings, Inc. (CTRI)**
- Source: The Globe and Mail | 20251207T034454 | Neutral | Relevance: 61%
-  Wells Fargo analyst Joe O’Dea maintained a Buy rating on Centuri Holdings, Inc. (CTRI) with a $25.00 price target. The company reported increased quarterly revenue of $850.04 million and a net profit of $2.1 million, and corporate insider sentiment is positive with increased insider buying, including a significant purchase by Carl Icahn.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | Oppenheimer | $228 | $225 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | Oppenheimer | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($1.40M) |
| Sells | 5 ($2.85M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 13.3% (+93.9%)
- Vanguard Group Inc: 12.1% (+0.2%)
- Blackrock Inc.: 7.3% (-3.2%)
- State Street Corpora: 4.8% (+1.3%)
- Geode Capital Manage: 2.5% (+1.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.13 elevated, pricing in significant growth expectations. Quality metrics strong (margin 28%). Balance sheet: strong liquidity (2.0x). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.1B |
| Beta | 1.31 |
| 52W Range | $143.04 - $222.31 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.13 |
| Forward P/E | 17.9 |
| Current P/E | 19.8 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.22% (CS: 61) | Neutral |
| RSI_14 | 66.2 | Neutral |
| MACD Histogram | 0.39 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.074x | Above |
| vs SMA200 | 1.069x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $190.08
- **Stop Loss:** $183.60 (3.4% risk)
- **Target:** $196.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $14,636.16
- **Portfolio %:** 14.64%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-29 (Est: $2.48)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.51 | $2.62 | +4.5% |
| 2025Q2 | $2.39 | $2.44 | +2.1% |
| 2025Q1 | $1.98 | $2.05 | +3.5% |
| 2024Q4 | $2.08 | $2.20 | +5.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*